Email this article 
The quality of life assessment after radical prostatectomy with usage of MEB questionnaire 13.1
- Authors: Al-Shukri S.H. 1, Nevirovich Y.S. 1, Al-Shukri A.S. 1, Boriskin A.G. 1, Tyurina Y.V. 1
- Affiliations:
- First St.-Petersburg State I. P. Pavlov Medical University
- Issue: Vol 3, No 3 (2013)
- Pages: 3-9
- Section: Articles
- URL: https://journals.eco-vector.com/uroved/article/view/2536
- DOI: https://doi.org/10.17816/uroved333-9
- Cite item
Open Access
Access granted
Abstract
Full Text
About the authors
Salman Hasunovich Al-Shukri
First St.-Petersburg State I. P. Pavlov Medical University
Email: al-shukri@mail.ru
doctor of medical science, professor, head of the department. Department of Urology.
Yevgeniy Stanislavovich Nevirovich
First St.-Petersburg State I. P. Pavlov Medical Universitycandidate of medical science, head of Urological Unit
Adel Salmanovich Al-Shukri
First St.-Petersburg State I. P. Pavlov Medical Universitydoctor of medical science, professor, Urology Department
Anton Gennadyevich Boriskin
First St.-Petersburg State I. P. Pavlov Medical University
Email: flounder@yandex.ru
candidate of medical science, assistant professor, Urology Department
Yuliya Valeryevna Tyurina
First St.-Petersburg State I. P. Pavlov Medical Universitystudent
References
- Hoffman R. M. Clinical Practice. Screening for Prostate Cancer // New Engl. J. Med. 2011. Vol. 365, N 21. P. 2013–2019.
- Lu-Yao G. L., Albertsen P. C., Moore D. F. et al. Outcomes of localized prostate cancer following conservative management // JAMA. 2009. Vol. 302, N 11. P. 1202–1209.
- Greene K. L., Albertsen P. C., Babaian R. J. et al. Prostate specific antigen best practice statement: 2009 update // J. Urol. 2009. Vol. 182, N 5. P. 2232–2241.
- Phillips C. Study questions benefit of surgery in some men with early-stage prostate cancer // NCI cancer bulletin. 2011. Vol. 8, N 11.
- Roobol M. J., Kerkhof M., Schroeder F. H. et al. Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC) //EurUrol. 2009. Vol. 56, N 4. P. 584–591.
- Thompson J. M.Jr., Goodman P. J., Tangen C. M. et al. Long-Term Survival of Participants in the Prostate Cancer Prevention Trial //New Engl. J. Med. 2013. Vol. 369, N 7. P. 603–610.
- Schroeder F. H., Hugosson J., Roobol M. J. et al. Prostate-Cancer Mortality at 11 Years of Follow-up // New Engl. J. Med. 2012. Vol. 366, N 11. P. 981–990.
- Bill-Axelson A., Holmberg L., Ruutu M. et al. Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer // New Engl. J. Med. 2011. Vol. 364, N 18. P 1708–1717.
